Navigation Links
Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
Date:1/31/2008

nded on NNRTIs as the base of my regimens," admitted Gary Rose, TIICANN's Chair. "It is a major relief for me to have a new option as my present regimen combining an NNRTI and a protease inhibitor which is both toxic and weakening. I think this is quite a common phenomena among patients with long-term exposure to antiretrovirals and so Tibotec's determination to develop new, non-cross resistant drugs for HIV, and just as importantly, oral compounds for hepatitis C - the company's dedication to virology is notable - is a cause for quiet celebration among infectious disease doctors and my fellow patients."

Congressman Maurice Hinchey, a TII CANN Board member stated: "Representing New York, which continues to bear the largest portion of the many burdens of the American AIDS epidemic, I'm very sensitive to any efforts to make new treatments affordable and accessible to all regardless of their financial circumstances or health insurance coverage. No HIV+ or AIDS patient should be denied access to critical drugs that can help them live longer and more productive lives."

Contact: Bill Arnold (202) 588-1775


'/>"/>
SOURCE The AIDS Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
3. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. Amylin Pharmaceuticals Reports 2007 Financial Results
5. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
6. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
7. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
8. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
9. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
10. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
11. Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Legislation passed in 2003 to slow the spiraling ... to treat Medicare patients has had no meaningful impact ... researchers in the Journal of Clinical Oncology ... outpatient chemotherapy to treat colorectal and lung cancers, and ... prescribe those drugs following the implementation of the recent ...
(Date:9/30/2014)... September 30, 2014 Integrated Medicine ... is opening another new medical specialty practice through a ... Cardiology will be located within the company’s Shrewsbury ... and Dr. Isaac Tawfik of American Heart Center, P.C., ... new practice will offer Integrated Medicine Alliance patients top ...
(Date:9/30/2014)... of allergy-related sudden deaths in the U.S., according to ... conducted by researchers at Montefiore Medical Center ... Yeshiva University . The study, published online today in ... also found that the risk of fatal drug-induced allergic ... and that such deaths increased significantly in the U.S. ...
(Date:9/30/2014)... EverStryke , the permanent match currently ... along with a free book and class all about survival ... prompting an investigative review. , “Joe Marshall of SurvivalLife.com ... and preparation niche, and this product is an excellent way ... survival products that Joe offers on his website to help ...
(Date:9/30/2014)... The American Diabetes Association ... curb their sweet tooth, but the most recent research, ... suggests that zero-calorie sweeteners may actually be linked to ... The Weizmann Institute of Science in Israel recently ... mice, the mice developed glucose intolerance. They then analyzed ...
Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2
... Medical Data ... the healthcare industry has announced the expansion in to Primary Collections Operations, and the opening ... ... industry leader, Medical Data Systems, Inc. (MDS), has announced the opening of its ...
... Reportlinker.com just added a new market research ... World Multiple Myeloma Therapeutics Market ... , , This ... Therapeutics in Millions of US$. The market for ...
... SCAN Health Plan announced today that it has hired ... services, effective immediately. Taylor-Laws brings more than 25 years ... vice president Taylor-Laws will be responsible for the development ... on behalf of SCAN,s members throughout Maricopa County. "Access ...
... 7 Twenty-one regional hospitals that utilize ... (INHS) earned the distinction of being among the most ... the 2009 Most Wired Survey and Benchmarking Study released ... Networks magazine. Hospitals and Health Networks ...
... for American Medical Innovation headlined a forum on medical ... Health. Former Democratic Majority Leader Richard Gephardt, president ... in Indiana government, academia and business for a panel ... and what is needed to maintain a robust environment ...
... The Anthropedia Foundation, a non-profit organization based in ... Yourself , an innovative DVD series designed for people ... lives. The series is a step-by-step guide to improving ... on straightforward concepts and simple exercises that foster calmness, ...
Cached Medicine News:Health News:Medical Data Systems, Inc. (MDS) Announces Operations Expansion and Opening of its Primary Collections Operations Office 2Health News:Medical Data Systems, Inc. (MDS) Announces Operations Expansion and Opening of its Primary Collections Operations Office 3Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 2Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 3Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 4Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 5Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 6Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 7Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 8Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 9Health News:SCAN Health Plan Selects Kathy Taylor-Laws as Vice President of Network Management Services 2Health News:21 Regional Hospitals Recognized as Nation's Most Wired 2Health News:21 Regional Hospitals Recognized as Nation's Most Wired 3Health News:Council for American Medical Innovation and Hoosiers Work for Health Host Indiana Forum on Medical Innovation 2Health News:Knowing Yourself Can Improve Your Health and Happiness 2Health News:Knowing Yourself Can Improve Your Health and Happiness 3
(Date:9/30/2014)... Sept. 30, 2014  According to their CEO, ... cancer clinical trials is going through a complete ... the work of the current clinical trial management ... ,next generation, clinical trials, which will ultimately drive ... The company has been recognized by the ...
(Date:9/30/2014)... , Sept. 30, 2014  Alimera Sciences, Inc. (NASDAQ: ... specializes in the research, development and commercialization of prescription ... $25 million advance from Hercules Technology Growth Capital, Inc. ... the second and final advance under the Loan and ... United Kingdom , Alimera Sciences Limited, entered into ...
(Date:9/30/2014)... 30, 2014 A study using a relatively ... new look at the composition of carotid artery disease ... and treat the disease, a leading cause of stroke. ... Lexington between September 2010 and May 2012, was featured ... of the American College of Cardiology (JACC) Cardiovascular Interventions. ...
Breaking Medicine Technology:Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
... Feb. 16, 2011 U.S. Marshals, at the ... yesterday seized all lots of Auralgan Otic Solution, ... inflammation associated with ear infections, from Integrated Commercialization ... manufactured for Deston Therapeutics, located in Chapel Hill, ...
... 16, 2011 Spending on specialty medications is growing ... medications can help slow disease progression and keep patients ... Specialty Pharmacy Solutions Elizabeth Mauer told participants at the ... Conference today. "Balancing the tremendous financial burden ...
Cached Medicine Technology:U.S. Marshals Seize Auralgan Otic Solution 2Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference 2
... oxygen flowmeters., ,Options: , ... S to model number. Example: ... add suffix C to model ... Double Flowmeters with Power Take-Off, ...
... flowmeters., ,Options: , For ... to model number. Example: FMC107S. ... suffix C to model number. ... Flowmeters with Power Take-Off, add ...
... Slim Line Flowmeters with brass and ... security chain, add suffix S to ... Canadian Color-Code, add suffix C to ... Double Flowmeters with Power Take-Off, add ...
... Flowmeters with brass and aluminum body., ... add suffix S to model number. ... add suffix C to model number. ... with Power Take-Off, add PT to ...
Medicine Products: